86 related articles for article (PubMed ID: 12021117)
1. Relation between course of disease in type 1 diabetes and islet cell antibodies.
Zamaklar M; Jotic A; Lalic N; Lalic K; Rajkovic N; Milicic T
Ann N Y Acad Sci; 2002 Apr; 958():251-3. PubMed ID: 12021117
[TBL] [Abstract][Full Text] [Related]
2. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
3. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
[TBL] [Abstract][Full Text] [Related]
4. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
[TBL] [Abstract][Full Text] [Related]
5. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
6. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
Bingley PJ; Christie MR; Bonifacio E; Bonfanti R; Shattock M; Fonte MT; Bottazzo GF; Gale EA
Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
[TBL] [Abstract][Full Text] [Related]
8. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
[TBL] [Abstract][Full Text] [Related]
9. Natural history of islet cell antibodies during the clinical period of type 1 diabetes. High titres at diagnosis are associated with longer persistence.
Goday A; Fernandez J; Gonzalez-Clemente JM; Ferrer J; Usach E; Gomis R; Vilardell E
Diabetes Res; 1991 Aug; 17(4):169-74. PubMed ID: 1823637
[TBL] [Abstract][Full Text] [Related]
10. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
Knip M; Karjalainen J; Akerblom HK
Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
[TBL] [Abstract][Full Text] [Related]
11. Islet-cell antibodies: markers of a more severe insulin-dependent diabetes mellitus?
Montaña E; Goday A; Rosel P; Casamitjana R; Soler J; Gomis R
Diabetes Res; 1989 Aug; 11(4):167-71. PubMed ID: 2625032
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
Kretowski A; Szelachowska M; Kinalska I
Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
[TBL] [Abstract][Full Text] [Related]
13. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
Gardner SG; Gale EA; Williams AJ; Gillespie KM; Lawrence KE; Bottazzo GF; Bingley PJ
Diabetes Care; 1999 Dec; 22(12):2049-54. PubMed ID: 10587841
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes.
Eskola V; Vähäsalo P; Akerblom HK; Knip M;
Horm Res; 2003; 59(4):195-200. PubMed ID: 12649574
[TBL] [Abstract][Full Text] [Related]
16. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for the course of beta cell function in autoimmune diabetes.
Törn C; Landin-Olsson M; Lernmark A; Palmer JP; Arnqvist HJ; Blohmé G; Lithner F; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L; Ostman J
J Clin Endocrinol Metab; 2000 Dec; 85(12):4619-23. PubMed ID: 11134117
[TBL] [Abstract][Full Text] [Related]
18. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
20. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
